GDTC
CytoMed Therapeutics Ltd
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 6-K | 9/30/2026 | View on SEC |
| 144 | 8/11/2026 | View on SEC |
| 4/A | 7/24/2026 | View on SEC |
| SCHEDULE 13D/A | 7/24/2026 | View on SEC |
| 4 | 7/24/2026 | View on SEC |
| 6-K | 6/23/2026 | View on SEC |
| 4 | 6/15/2026 | View on SEC |
| 6-K | 6/3/2026 | View on SEC |
| 3 | 5/26/2026 | View on SEC |
| 3 | 5/15/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GDTC |
| Company Name | CytoMed Therapeutics Ltd |
| CIK | 1873093 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | U0 |
| Phone | 603824911 |